1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Antimicrobial Surgical Suture Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Antimicrobial Surgical Suture Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Antimicrobial Surgical Suture Market Regional Analysis
6.2 North America Antimicrobial Surgical Suture Market Revenue 2021-2031 (US$ Million)
6.3 North America Antimicrobial Surgical Suture Market Forecast Analysis
7. North America Antimicrobial Surgical Suture Market Analysis – by Type
7.1 Triclosan Antimicrobial Suture
- 7.1.1 Overview
- 7.1.2 Triclosan Antimicrobial Suture: North America Antimicrobial Surgical Suture Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Chlorhexidine Antimicrobial Suture
- 7.2.1 Overview
- 7.2.2 Chlorhexidine Antimicrobial Suture: North America Antimicrobial Surgical Suture Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. North America Antimicrobial Surgical Suture Market Analysis – by Raw Materials
8.1 Polyglactin 910 Antimicrobial Suture
- 8.1.1 Overview
- 8.1.2 Polyglactin 910 Antimicrobial Suture: North America Antimicrobial Surgical Suture Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Poliglecaprone 25
- 8.2.1 Overview
- 8.2.2 Poliglecaprone 25: North America Antimicrobial Surgical Suture Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Polyglycolic Acid
- 8.3.1 Overview
- 8.3.2 Polyglycolic Acid: North America Antimicrobial Surgical Suture Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. North America Antimicrobial Surgical Suture Market Analysis – by Application
9.1 Cardiovascular Surgery
- 9.1.1 Overview
- 9.1.2 Cardiovascular Surgery: North America Antimicrobial Surgical Suture Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 General Surgery
- 9.2.1 Overview
- 9.2.2 General Surgery: North America Antimicrobial Surgical Suture Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Ophthalmic Surgery
- 9.3.1 Overview
- 9.3.2 Ophthalmic Surgery: North America Antimicrobial Surgical Suture Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.4 Gynecological Surgery
- 9.4.1 Overview
- 9.4.2 Gynecological Surgery: North America Antimicrobial Surgical Suture Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.5 Orthopedic Surgery
- 9.5.1 Overview
- 9.5.2 Orthopedic Surgery: North America Antimicrobial Surgical Suture Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.6 Plastic Surgery
- 9.6.1 Overview
- 9.6.2 Plastic Surgery: North America Antimicrobial Surgical Suture Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.7 Veterinary Surgery
- 9.7.1 Overview
- 9.7.2 Veterinary Surgery: North America Antimicrobial Surgical Suture Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.8 Dental Surgery
- 9.8.1 Overview
- 9.8.2 Dental Surgery: North America Antimicrobial Surgical Suture Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.9 Others
- 9.9.1 Overview
- 9.9.2 Others: North America Antimicrobial Surgical Suture Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. North America Antimicrobial Surgical Suture Market Analysis – by End User
10.1 Hospitals
- 10.1.1 Overview
- 10.1.2 Hospitals: North America Antimicrobial Surgical Suture Market – Revenue and Forecast, 2021-2031 (US$ Million)
10.2 Ambulatory Surgical Centers
- 10.2.1 Overview
- 10.2.2 Ambulatory Surgical Centers: North America Antimicrobial Surgical Suture Market – Revenue and Forecast, 2021-2031 (US$ Million)
10.3 Others
- 10.3.1 Overview
- 10.3.2 Others: North America Antimicrobial Surgical Suture Market – Revenue and Forecast, 2021-2031 (US$ Million)
11. North America Antimicrobial Surgical Suture Market – North America Analysis
11.1 Overview
11.2 North America
- 11.2.1 North America Antimicrobial Surgical Suture Market Breakdown, by Key
Country, 2024 and 2031 (%)
- 11.2.1.1 North America Antimicrobial Surgical Suture Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 US:
North America Antimicrobial Surgical Suture Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.1.1 US: North America Antimicrobial Surgical Suture Market Breakdown, by Type
- 11.2.1.1.2 US: North America Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
- 11.2.1.1.3 US: North America Antimicrobial Surgical Suture Market Breakdown, by Application
- 11.2.1.1.4 US: North America Antimicrobial Surgical Suture Market Breakdown, by End User
- 11.2.1.2 Canada:
North America Antimicrobial Surgical Suture Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.2.1 Canada: North America Antimicrobial Surgical Suture Market Breakdown, by Type
- 11.2.1.2.2 Canada: North America Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
- 11.2.1.2.3 Canada: North America Antimicrobial Surgical Suture Market Breakdown, by Application
- 11.2.1.2.4 Canada: North America Antimicrobial Surgical Suture Market Breakdown, by End User
- 11.2.1.3 Mexico:
North America Antimicrobial Surgical Suture Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.3.1 Mexico: North America Antimicrobial Surgical Suture Market Breakdown, by Type
- 11.2.1.3.2 Mexico: North America Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
- 11.2.1.3.3 Mexico: North America Antimicrobial Surgical Suture Market Breakdown, by Application
- 11.2.1.3.4 Mexico: North America Antimicrobial Surgical Suture Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Advanced MedTech Solutions Pvt. Ltd.
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Cencora, Inc. (AmerisourceBergen Corporation)
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Healthium Medtech Limited
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Internacional Farmaceutica SA
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Johnson & Johnson
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Meril Life Sciences Pvt Ltd
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 TI Medical
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Unilene
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations